Bingham Osborn & Scarborough’s Eli Lilly LLY Stock Holding History

Bingham Osborn & Scarborough’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,427	Closed	-$561K	–	86
2021 Q3	$561K	Buy	2,427 +126	+5%	+$31.1K	0.04%	81
2021 Q2	$528K	Sell	2,301 -36	-2%	-$7.23K	0.04%	82
2021 Q1	$437K	Buy	2,337 +813	+53%	+$159K	0.03%	88
2020 Q4	$257K	Sell	1,524 -1,009	-40%	-$151K	0.02%	115
2020 Q3	$375K	Sell	2,533 -172	-6%	-$26.6K	0.03%	111
2020 Q2	$444K	Sell	2,705 -24	-0.9%	-$3.68K	0.04%	92
2020 Q1	$379K	Buy	2,729 +939	+52%	+$129K	0.04%	98
2019 Q4	$235K	Sell	1,790 -26	-1%	-$3.01K	0.02%	148
2019 Q3	$203K	Buy	+1,816	New	+$202K	0.02%	150
2019 Q2	–	Sell	-1,756	Closed	-$228K	–	149
2019 Q1	$228K	Sell	1,756 -1,264	-42%	-$154K	0.02%	131
2018 Q4	$349K	Buy	+3,020	New	+$337K	0.04%	98

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bingham Osborn & Scarborough's LLY Position: Q4 2021 in Review

Bingham Osborn & Scarborough sold out of Eli Lilly (LLY) in Q4 2021, closing a stake of 2,427 shares — an estimated $561K sold.

Bingham Osborn & Scarborough first reported a position in LLY in Q4 2018 and held it in 11 quarters. The position peaked at $561K in Q3 2021. 2,303 funds tracked by Wall St. Rank hold LLY as of Q4 2021.

Bingham Osborn & Scarborough reported no remaining Eli Lilly position as of Q4 2021 after selling out during the quarter.
Bingham Osborn & Scarborough sold 2,427 Eli Lilly shares in Q4 2021, an estimated $561K.
Bingham Osborn & Scarborough first reported a position in Eli Lilly in Q4 2018 and held it in 11 quarters.
Bingham Osborn & Scarborough's Eli Lilly position peaked at $561K in Q3 2021.
2,303 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.

Based on Bingham Osborn & Scarborough's 13F filing for Q4 2021.